Millennium Management
IMUX icon

Millennium Management’s Immunic IMUX Stock Holding History

Millennium Management’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-33,050
Closed -$1.15M – 7254
2022
Q2 		$1.15M Buy
33,050
+15,550
+89% +$996K ﹤0.01% 4245
2022
Q1 		$1.98M Buy
+17,500
New +$2.03M ﹤0.01% 3893

Other funds holding IMUX

APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

Millennium Management's IMUX Position: Q1 2026 in Review

Millennium Management increased its Immunic (IMUX) stake by 11% in Q1 2026, buying an estimated $323K and bringing the position to 377,992 shares worth $4.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3153.

Millennium Management first reported a position in IMUX in Q4 2016 and has held it in 34 quarters since. The position peaked at $5.93M in Q1 2022. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

  • Millennium Management held 377,992 shares of Immunic worth $4.2M as of Q1 2026.
  • Millennium Management bought 36,062 Immunic shares in Q1 2026, an estimated $323K.
  • Immunic made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #3153 holding.
  • Millennium Management first reported a position in Immunic in Q4 2016 and has held it in 34 quarters since.
  • Millennium Management's Immunic position peaked at $5.93M in Q1 2022.
  • 75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.